Recent Advances in Physiologically Based Biopharmaceutics Modeling
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 91
Special Issue Editor
Special Issue Information
Dear Colleagues,
The quantitative prediction of the pharmacokinetics, especially the absorption kinetics, of orally administered drugs has been investigated by many researchers. However, oral absorption is an amalgamation of many disciplines, including pharmacokinetics, formulation science, the physical chemistry of drugs, and physiology in the gastrointestinal tract of humans; research that achieves accurate prediction is still in its infancy. Needless to say, physiologically based biopharmaceutics modeling (PBBM) has attracted attention in the field of pharmaceutics in recent years as an approach to solving this problem. It is important to understand the benefits and current challenges of PBBM by having many case studies presented in a journal.
This Special Issue focuses on PBBM research in drug product development and clinical development. This Special Issue will include modeling and simulation approaches to forecast or evaluate the relative BA and BE between drug formulations, modeling approaches to predict the effects of food ingestion and concomitant medications on drug absorption, as well as studies discussing the relationship between drug formulation quality (such as API particle size and dissolution test specifications) and PBBM. It is hoped that this Special Issue will lead to the appropriate scientific use of PBBM and patient-centered drug development and drug approval review.
Dr. Atsushi Kambayashi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oral drug absorption
- bioavailability
- bioequivalence
- modeling and simulation
- physiologically based biopharmaceutics modeling
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
